Sugi Predict

Sugi Predict / Compounds / SCHEMBL13628953

SCHEMBL13628953

SCHEMBL13628953

CNC(=O)c1c(I)cc(I)cc1I

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 1/20 0.44
▸ TP53 P04637 1/20 0.37
▸ PLK1 P53350 3/20 0.36
▸ HDAC8 Q9BY41 2/20 0.35
▸ HDAC6 Q9UBN7 2/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ CREBBP Q92793 1/20 0.34
▸ BAZ2B Q9UIF8 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ERN1 O75460 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ NLRP3 Q96P20 1/20 0.33
▸ EGFR P00533 4/20 0.33
▸ SRC P12931 2/20 0.33
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9787542 0.78 HDAC8 (0.37) TP53PLK1HDAC8HDAC6HDAC2
SCHEMBL13906690 0.77 TTR (0.39) TTRHDAC6HPGDTSHRGAA
SCHEMBL24506701 0.75 TP53 (0.43) TTRTP53PLK1HDAC8HDAC6
SCHEMBL22097499 0.75 SCN9A (0.38) TTR
SCHEMBL7158495 0.75 TSHR (0.46) TP53HDAC8HDAC6HDAC2CREBBP
SCHEMBL15284299 0.74 HDAC8 (0.50) PLK1HDAC8HDAC6HDAC2HPGD
SCHEMBL9318772 0.74 TP53 (0.36) TP53HDAC8HDAC6HDAC2CREBBP
SCHEMBL10498088 0.73 TTR (0.50) TTRHPGDSMN1; SMN2ERN1POLB
SCHEMBL25477911 0.73 CA12 (0.45) TTRHPGDTSHRPOLBGAA
SCHEMBL16569007 0.72 TP53 (0.41) TP53TSHRHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107778191-A A kind of preparation method of Iopromide and its intermediate 正大天晴药业集团股份有限公司 2018-03-09 — — CN disclosed
US-20090280064-A1 TRANSDERMAL DELIVERY OF OPTICAL, SPECT, MULTIMODAL, DRUG OR BIOLOGICAL CARGO LADEN NANOPARTICLE(S) IN SMALL ANIMALS OR HUMANS CARESTREAM HEALTH, INC. 2009-11-12 — — US disclosed
US-20090180964-A1 TRANSMUCOSAL DELIVERY OF OPTICAL, SPECT, MULTIMODAL,DRUG OR BIOLOGICAL CARGO LADEN NANOPARTICLE(S) IN SMALL ANIMALS OR HUMANS QUANTUM MEDICAL HOLDINGS, LLC 2009-07-16 — — US disclosed
US-20090093700-A1 APPARATUS AND METHOD FOR MULTI-MODAL IMAGING USING NANOPARTICLE MULTI-MODAL IMAGING PROBES CARESTREAM HEALTH, INC. 2009-04-09 — — US disclosed
US-20090086908-A1 APPARATUS AND METHOD FOR MULTI-MODAL IMAGING USING NANOPARTICLE MULTI-MODAL IMAGING PROBES CARESTREAM HEALTH, INC. 2009-04-02 — — US disclosed
WO-2009032235-A1 APPARATUS AND METHOD FOR MULTI-MODAL IMAGING CARESTREAM HEALTH, INC. (US) 2009-03-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090180964-A1 TRANSMUCOSAL DELIVERY OF OPTICAL, SPECT, MULTIMODAL,DRUG OR BIOLOGICAL CARGO LADEN NANOPARTICLE(S) IN SMALL ANIMALS OR HUMANS FABP2, PIGS, SLC35A1 TTR 338/4885TP53 3058/4885PLK1 3184/4885
US-20090280064-A1 TRANSDERMAL DELIVERY OF OPTICAL, SPECT, MULTIMODAL, DRUG OR BIOLOGICAL CARGO LADEN NANOPARTICLE(S) IN SMALL ANIMALS OR HUMANS PIGS, CUTA, CD68 TTR 479/4885TP53 1261/4885PLK1 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.